ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

9.81

+0.05 (0.51%)

At close: Jun 15, 2026, 4:00 PM EDT

9.80

-0.01 (-0.10%)

Pre-market: Jun 16, 2026, 7:17 AM EDT

ARS Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.32	41.32	50.82	70.97	210.52	60.06
Short-Term Investments	176.65	203.67	263.21	157.39	63.86	-
Cash & Short-Term Investments	200.97	244.99	314.02	228.36	274.38	60.06
Cash Growth	-27.11%	-21.98%	37.51%	-16.77%	356.82%	-84.46%
Accounts Receivable	28.66	25.35	8.18	-	-	-
Inventory	8.82	8.37	5.21	-	-	-
Other Current Assets	6.79	6.19	6.89	3.37	3.32	0.67
Total Current Assets	245.24	284.9	334.3	231.73	277.7	60.73
Net Property, Plant & Equipment	2.29	2.47	1.07	0.82	0.77	0.69
Other Intangible Assets	14.18	14.45	7.37	-	-	-
Other Long-Term Assets	25.87	25.84	8.42	0.64	2.96	0.02
Total Assets	287.57	327.65	351.15	233.19	281.44	61.45
Accounts Payable	48.26	37.95	22.84	2.15	4.93	3.11
Short-Term Debt	-	-	-	-	-	3.48
Current Portion of Leases	0.59	0.59	0.04	0.24	0.23	0.14
Unearned Revenue	0.76	0.61	0.56	-	0.28	1.46
Total Current Liabilities	49.61	39.15	23.44	2.39	5.44	8.19
Long-Term Debt	96.52	96.37	-	-	-	4.93
Long-Term Leases	-	-	-	0.04	0.25	0.48
Other Long-Term Liabilities	80.13	77.88	70.92	-	2.85	3.08
Total Long-Term Liabilities	176.65	174.25	70.92	0.04	3.11	8.49
Total Liabilities	226.26	213.39	94.36	2.43	8.55	16.68
Common Stock	-	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	-	408.73	379.87	362	349.41	10.98
Accumulated Other Comprehensive Income	-0.1	0.13	0.22	0.05	0.41	-
Retained Earnings	-	-294.6	-123.31	-131.3	-76.94	-42.26
Total Common Shareholders' Equity	-0.1	114.26	256.8	230.76	272.89	-31.27
Minority Interest	-	-	-	-	-	76.04
Shareholders' Equity	-0.1	114.26	256.8	230.76	272.89	44.77
Total Liabilities & Equity	287.57	327.65	351.15	233.19	281.44	61.45
Total Debt	97.11	96.96	0.04	0.27	0.48	9.03
Net Cash (Debt)	103.86	148.02	313.98	228.09	273.9	51.03
Net Cash Growth	-29.84%	-52.86%	37.66%	-16.73%	436.74%	-86.66%
Net Cash Per Share	1.05	1.50	3.07	2.40	6.86	1.77
Book Value	-0.1	114.26	256.8	230.76	272.89	-31.27
Book Value Per Share	-0.00	1.16	2.51	2.42	6.83	-1.08
Tangible Book Value	-14.27	99.81	249.43	230.76	272.89	-31.27
Tangible Book Value Per Share	-0.14	1.01	2.44	2.42	6.83	-1.08

SEC Filings: 10-K · 10-Q